As part of the deal, Eli Lilly would pay almost $1bn upfront for Verve, which is developing a gene-editing therapy to treat bad cholesterol, and a further $300mn based on the biotech company achieving ...

The war between the Sudan Armed Forces (SAF) and Rapid Support Forces (RSF) has exacerbated overcrowding in the town, as ...